MAXIMUS, Inc. (NYSE:MMS) Short Interest Update

Share on StockTwits

MAXIMUS, Inc. (NYSE:MMS) was the target of a significant decline in short interest in the month of September. As of September 15th, there was short interest totalling 1,230,000 shares, a decline of 9.6% from the August 31st total of 1,360,000 shares. Based on an average daily volume of 327,200 shares, the short-interest ratio is currently 3.8 days. Currently, 2.0% of the shares of the company are short sold.

MMS traded down $1.05 during midday trading on Friday, reaching $67.84. The company had a trading volume of 253,890 shares, compared to its average volume of 424,553. The stock has a market cap of $4.16 billion, a PE ratio of 20.50 and a beta of 0.89. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.95 and a current ratio of 1.95. The business has a 50-day moving average price of $73.78 and a two-hundred day moving average price of $69.09. MAXIMUS has a 12-month low of $46.42 and a 12-month high of $80.50.

MAXIMUS (NYSE:MMS) last announced its quarterly earnings results on Thursday, August 6th. The health services provider reported $1.04 EPS for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.26. The company had revenue of $901.34 million for the quarter, compared to analysts’ expectations of $801.31 million. MAXIMUS had a net margin of 6.41% and a return on equity of 17.29%. MAXIMUS’s revenue was up 23.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.97 EPS. On average, research analysts anticipate that MAXIMUS will post 3.27 earnings per share for the current year.

In related news, CEO Bruce Caswell sold 23,303 shares of the business’s stock in a transaction dated Wednesday, September 30th. The stock was sold at an average price of $68.41, for a total transaction of $1,594,158.23. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Vice Chairman Richard A. Montoni sold 11,000 shares of the business’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $72.50, for a total value of $797,500.00. The disclosure for this sale can be found here. Insiders sold 70,445 shares of company stock worth $4,927,372 over the last quarter. 2.00% of the stock is currently owned by corporate insiders.

A number of large investors have recently modified their holdings of the stock. Signaturefd LLC lifted its position in MAXIMUS by 237.0% during the second quarter. Signaturefd LLC now owns 1,112 shares of the health services provider’s stock worth $78,000 after buying an additional 782 shares during the period. Public Employees Retirement System of Ohio bought a new stake in MAXIMUS during the 2nd quarter valued at $92,000. Parallel Advisors LLC raised its stake in MAXIMUS by 36.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,508 shares of the health services provider’s stock valued at $106,000 after acquiring an additional 402 shares in the last quarter. Advisor Group Holdings Inc. bought a new stake in MAXIMUS during the 1st quarter valued at $160,000. Finally, Value Holdings Management CO. LLC bought a new stake in MAXIMUS during the 1st quarter valued at $174,000. Institutional investors own 94.19% of the company’s stock.

Several equities analysts recently issued reports on the company. TheStreet upgraded MAXIMUS from a “c+” rating to a “b-” rating in a research note on Tuesday, July 28th. KeyCorp upped their price objective on MAXIMUS from $80.00 to $84.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. Finally, Raymond James upgraded MAXIMUS from a “market perform” rating to a “strong-buy” rating and set a $90.00 price objective on the stock in a research note on Wednesday, July 8th. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. MAXIMUS presently has an average rating of “Buy” and an average price target of $83.50.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Recommended Story: Hedge Funds – How They Work For Investors

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply